crpharm.comCrawled Oct 21, 2026
China Resources Pharmaceutical Group Limited operates as a leading integrated healthcare company, engaging in manufacturing, distribution, and retail of pharmaceuticals and healthcare products. The company is listed on the Hong Kong Stock Exchange and included in multiple global indices, such as the Hang Seng Composite Medium Cap Index, Hang Seng Techex Index, Hang Seng China Enterprise Index, and MSCI China Index.
China Resources Pharmaceutical Group Limited operates as a leading integrated healthcare company, engaging in manufacturing, distribution, and retail of pharmaceuticals and healthcare products. The company is listed on the Hong Kong Stock Exchange and included in multiple global indices, such as the Hang Seng Composite Medium Cap Index, Hang Seng Techex Index, Hang Seng China Enterprise Index, and MSCI China Index.
Baird Medical partners with China Resources Pharmaceutical Commercial Group to distribute microwave ablation devices in China. The agreement includes an initial order valued at approximately RMB 6 million ($900,000) to expand market access for the medical technology. The collaboration aims to strengthen Baird Medical’s presence in the Chinese healthcare sector.
Nov 2026Stock TitanNews article
China Resources Pharmaceutical Group (3320.HK) sees a 2.12% increase in share price on October 26. The company’s stock movement reflects broader market trends without additional context on specific drivers.
Oct 2026Global Banking & Finance ReviewNews article
China Resources Pharmaceutical Group’s stock price drops by 2.79% in a single trading session. The decline follows broader market movements without specific company-related announcements. Investors react to general market sentiment amid economic uncertainties in the region.
Oct 2026Global Banking & Finance ReviewNews article
China Resources Pharmaceutical Group reports **2.0% revenue growth to RMB134.5 billion**, with net profit reaching **RMB5.02 billion** and earnings per share at **RMB0.35**. Distribution, retail, and manufacturing segments drive performance, while strategic mergers, R&D investments, and digital initiatives bolster resilience amid regulatory changes.
Aug 2026TradingViewNews article

China Resources Pharmaceutical Group, an integrated pharmaceutical company, manufactures and distributes medicines, health products, and medical devices.